691 related articles for article (PubMed ID: 24630619)
21. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
[TBL] [Abstract][Full Text] [Related]
22. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting.
Brett McQueen R; Perez-Nieves M; Todd Alonso G; Fan L; Hankosky ER; Shah VN; Yan Y; Ellis SL; Juneja R
Diabetes Res Clin Pract; 2024 Jun; 212():111690. PubMed ID: 38697300
[TBL] [Abstract][Full Text] [Related]
23. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
Uemura F; Okada Y; Torimoto K; Tanaka Y
Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
[TBL] [Abstract][Full Text] [Related]
24. Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.
Joubert M; Reznik Y
Diabetes Res Clin Pract; 2012 Jun; 96(3):294-305. PubMed ID: 22209014
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
26. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
[TBL] [Abstract][Full Text] [Related]
27. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
Su JB; Wang XQ; Chen JF; Wu G; Jin Y
Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
[TBL] [Abstract][Full Text] [Related]
28. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
[TBL] [Abstract][Full Text] [Related]
29. CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.
Buckingham B; Cheng P; Beck RW; Kollman C; Ruedy KJ; Weinzimer SA; Slover R; Bremer AA; Fuqua J; Tamborlane W;
Diabetologia; 2015 Jun; 58(6):1167-74. PubMed ID: 25773405
[TBL] [Abstract][Full Text] [Related]
30. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
[TBL] [Abstract][Full Text] [Related]
31. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
[TBL] [Abstract][Full Text] [Related]
32. Glucose Variability: A Review of Clinical Applications and Research Developments.
Rodbard D
Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
[TBL] [Abstract][Full Text] [Related]
33. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
Stewart ZA; Thomson L; Murphy HR; Beardsall K
Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
[TBL] [Abstract][Full Text] [Related]
34. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
Christensen MB; Gæde P; Hommel E; Gotfredsen A; Nørgaard K
Diabetes Metab; 2020 Feb; 46(1):61-65. PubMed ID: 30796973
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
[TBL] [Abstract][Full Text] [Related]
36. Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Monnier L; Wojtusciszyn A; Molinari N; Colette C; Renard E; Owens D
Diabetes Care; 2020 Apr; 43(4):821-827. PubMed ID: 31988062
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes.
Rodbard HW; Peters AL; Slee A; Cao A; Traina SB; Alba M
Diabetes Care; 2017 Feb; 40(2):171-180. PubMed ID: 27899497
[TBL] [Abstract][Full Text] [Related]
38. Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration.
Reaven PD; Newell M; Rivas S; Zhou X; Norman GJ; Zhou JJ
Diabetes Care; 2023 Apr; 46(4):854-863. PubMed ID: 36807492
[TBL] [Abstract][Full Text] [Related]
39. Comparison of insulin detemir and insulin glargine on glycemic variability in patients with type 1 and type 2 diabetes.
Tone A; Iseda I; Higuchi C; Tsukamoto K; Katayama A; Matsushita Y; Hida K; Wada J; Shikata K
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):320-4. PubMed ID: 20072962
[TBL] [Abstract][Full Text] [Related]
40. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
Billings LK; Parkin CG; Price D
Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
